Spatiotemporal distribution and determinants of measles incidence during a large outbreak, Italy, September 2016 to July 2018.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
Apr 2019
Historique:
entrez: 2 5 2019
pubmed: 2 5 2019
medline: 24 6 2020
Statut: ppublish

Résumé

BackgroundMeasles is still endemic in Italy and outbreaks are frequent. From 2016 to 2018, more than 7,000 measles cases were reported to the national integrated measles and rubella surveillance system, the largest outbreak since implementation of this system.AimWe aimed to describe the characteristics and spatiotemporal distribution of measles cases in Italy and explore determinants of incidence at municipality level.MethodsWe performed a retrospective observational study, mapping by municipalityall measles cases reported to the national surveillance system with symptom onset between 1 September 2016 and 31 July 2018. We also analysed measles-mumps-rubella (MMR) vaccination coverage (VC) data (2000-2017) for the first and second dose, collected from the Ministry of Health. We used regression analysis to explore factors associated with measles incidence at municipality level.ResultsWe analysed 7,854 cases, 3,927 (50%) female. Median age was 26 years; 475 cases (6%) were younger than 1 year. The outbreak occurred in two epidemic waves. The first started in central/northern regions (end of 2016), the second (mostly within 2018) was concentrated in southern regions. In 2016 and 2017, national VC was below 95% for both MMR doses. In 2017, only one region reported VC above 95% for the first dose. At municipality level, incidence was associated with higher urbanisation, less deprivation and fewer adults.ConclusionThe spread of measles between September 2016 and July 2018 in Italy indicates the need to improve VC and to explore further how societal and other parameters might be linked to incidence.

Identifiants

pubmed: 31039836
doi: 10.2807/1560-7917.ES.2019.24.17.1800679
pmc: PMC6628759
doi:

Substances chimiques

Measles-Mumps-Rubella Vaccine 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Références

Epidemiol Infect. 1998 Dec;121(3):645-52
pubmed: 10030715
Bull World Health Organ. 2000;78(8):950-5
pubmed: 10994277
Epidemiol Infect. 2002 Jun;128(3):479-84
pubmed: 12113493
Pediatr Infect Dis J. 2002 Aug;21(8):763-8
pubmed: 12192166
J Infect Dis. 2004 May 1;189 Suppl 1:S4-16
pubmed: 15106083
Euro Surveill. 2004 Apr;9(4):19-21
pubmed: 15192262
Euro Surveill. 2010 Sep 09;15(36):null
pubmed: 20843472
Euro Surveill. 2011 Jul 21;16(29):null
pubmed: 21801692
Euro Surveill. 2012 Dec 06;17(49):null
pubmed: 23231894
Euro Surveill. 2013 May 16;18(20):null
pubmed: 23725868
BMJ Open. 2017 Mar 30;7(3):e014106
pubmed: 28363926
PLoS Comput Biol. 2017 Apr 4;13(4):e1005474
pubmed: 28376097
Aust N Z J Public Health. 2017 Oct;41(5):455-457
pubmed: 28664595
Epidemiol Prev. 2017 May-Aug;41(3-4):187-196
pubmed: 28929715
Euro Surveill. 2017 Sep 14;22(37):null
pubmed: 28933342
Vaccine. 2018 Feb 1;36(6):779-787
pubmed: 29325822
BMC Public Health. 2018 Feb 20;18(1):269
pubmed: 29458349
Ann Ig. 2018 Mar-Apr;30(2):77-85
pubmed: 29465145
Nature. 2018 Mar 1;555(7694):30
pubmed: 29493608
Front Public Health. 2018 Jul 27;6:209
pubmed: 30140666
Sci Rep. 2018 Oct 31;8(1):16124
pubmed: 30382120
Emerg Infect Dis. 2019 Apr;25(4):625-632
pubmed: 30698523

Auteurs

Xanthi D Andrianou (XD)

European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Department of Infectious Diseases, National Institute of Health (Istituto Superiore di Sanità), Rome, Italy.

Martina Del Manso (M)

Department of Infectious Diseases, National Institute of Health (Istituto Superiore di Sanità), Rome, Italy.

Antonino Bella (A)

Department of Infectious Diseases, National Institute of Health (Istituto Superiore di Sanità), Rome, Italy.

Maria Fenicia Vescio (MF)

Department of Infectious Diseases, National Institute of Health (Istituto Superiore di Sanità), Rome, Italy.

Melissa Baggieri (M)

Department of Infectious Diseases, National Institute of Health (Istituto Superiore di Sanità), Rome, Italy.

Maria Cristina Rota (MC)

Department of Infectious Diseases, National Institute of Health (Istituto Superiore di Sanità), Rome, Italy.

Patrizio Pezzotti (P)

Department of Infectious Diseases, National Institute of Health (Istituto Superiore di Sanità), Rome, Italy.

Antonietta Filia (A)

Department of Infectious Diseases, National Institute of Health (Istituto Superiore di Sanità), Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH